(Reuters) - The cost-cutting plan is expected to generate pretax cost
savings of $1.3 billion to $1.6 billion in 2008, the
diversified health care company said.
The company is targeting savings in its pharmaceuticals
division, where it will consolidate certain operations. The
company noted that it faces major patent expirations over the
next few years to several drugs.
Read more at Reuters.com Market News
savings of $1.3 billion to $1.6 billion in 2008, the
diversified health care company said.
The company is targeting savings in its pharmaceuticals
division, where it will consolidate certain operations. The
company noted that it faces major patent expirations over the
next few years to several drugs.
Read more at Reuters.com Market News
No comments:
Post a Comment